Events2Join

Efficacy of topical and systemic treatments for atopic dermatitis on ...


Efficacy of topical and systemic treatments for atopic dermatitis on ...

All treatments had a positive effect on pruritus, with a mean overall reduction of 3.32/10, 95% IC [2.32-4.33].

Efficacy of topical and systemic treatments for atopic dermatitis on ...

A systematic literature review and a meta-analysis were conducted to evaluate and compare the effects of treatment used in AD on pruritus.

Efficacy of topical and systemic treatments for atopic dermatitis on ...

A total of five studies were included in the meta- analysis. All treatments had a positive effect on pruritus, with a mean overall reduction of 3.32/10, 95% IC ...

Topical treatments for atopic dermatitis (eczema): Systematic review ...

With moderate- to high-certainty evidence, group 5 TCS improved 6—among the best for 3; group 4 TCS and delgocitinib improved 4—among the best ...

Systemic treatments for atopic dermatitis (eczema): Systematic ...

Dupilumab, lebrikizumab, and tralokinumab are of intermediate effectiveness and have favorable safety. Key words. Atopic dermatitis (eczema) ...

Efficacy of topical and systemic treatments for atopic dermatitis on ...

A total of five studies were included in the meta- analysis. All treatments had a positive effect on pruritus, with a mean overall reduction of ...

Systemic Immunomodulatory Treatments for Atopic Dermatitis

Meaning These findings indicate that lebrikizumab, a new biologic medication, has comparable efficacy to dupilumab for the treatment of atopic ...

Full article: Novel topical and systemic therapies in atopic dermatitis

It is revealed that topical phosphodiesterase 4 inhibitors and Janus kinase (JAK) inhibitors are promising treatments for AD. Moreover, systemic therapies such ...

Systemic treatments for atopic dermatitis (eczema): Systematic ...

With high-certainty evidence, dupilumab, lebrikizumab, and tralokinumab were of intermediate effectiveness and among the safest, modestly increasing ...

Effectiveness and safety of systemic therapy for moderate-to-severe ...

In children aged 6 to 12 years, 33.0%-59.0% of atopic dermatitis patients achieved EASI-75, and when combined with topical corticosteroids (TCS) ...

Guidelines of care for the management of atopic dermatitis in adults ...

For people with atopic dermatitis (AD) refractory to topical therapies, treatment with phototherapy and systemic therapies can be considered ...

Systemic Immunomodulatory Treatments for Atopic Dermatitis

Systemic immunomodulatory agents used to treat atopic dermatitis include cyclosporine, methotrexate, azathioprine, mycophenolate, and dupilumab, ...

Emerging Systemic Treatments for Atopic Dermatitis

Classical treatment options include topical corticosteroids and calcineurin inhibitors, phototherapy, and systemic immunosuppression with oral corticosteroids.

Patients' preferences for systemic treatment of atopic dermatitis

Most cases of AD can be managed with topical treatments and/or phototherapy. However, if these therapies are not feasible or fail, systemic therapy is ...

Treatment of atopic dermatitis (eczema) - UpToDate

Outline · Nonpharmacologic interventions · Topical treatments · Phototherapy · Oral antihistamines · Cyclosporine · Dupilumab · Tralokinumab · JAK inhibitors.

Efficacy and Treatment Satisfaction of Different Systemic Therapies ...

For the treatment of moderate-to-severe atopic dermatitis in children and adolescents, the monoclonal antibody dupilumab and the selective JAK-1 inhibitor ...

Non‐biologic systemic treatments for atopic dermatitis: Current state ...

A systematic review and meta-analysis of 12 studies showed that after just 2 weeks of treatment with 3 mg/kg CyA, disease severity decreased by ...

Expert Perspectives on Management of Moderate-to-Severe Atopic ...

Although offering higher efficacy than topical treatments, systemic corticosteroids are not recommended by treatment guidelines because of short- and long ...

393 Comparative efficacy of targeted systemic therapies for ...

Abstract. The landscape of targeted systemic treatments for moderate-to-severe atopic dermatitis (AD) continues to expand.

Comparative Efficacy of Targeted Systemic Therapies for Moderate ...

The treatment landscape for moderate-to-severe atopic dermatitis (AD) continues to expand. This network meta-analysis (NMA) updates a previously ...